IperionX

IperionX plans to move its legal domicile to the US by creating a new parent company under Texas law, subject to approval by shareholders, courts, regulators and exchanges. The aim is a direct listing of the common shares on the NASDAQ and the replacement of the existing American Depositary Shares, with no changes to assets, operations or strategy. The company cites alignment with its US sites in Tennessee, Virginia and Utah as well as US customers and government-supported programs as the rationale. Michael J. Loparco was also appointed as an independent, non-executive director. » More on de.investing.com

IperionX is offering 2,275,000 American Depositary Shares (each ADS = 10 common shares) at $21.98 and expects gross proceeds of about $50 million, representing a discount to the current price of $25.85. The offering was largely subscribed by U.S. institutional investors and is expected to close promptly subject to customary conditions. Proceeds will be used for commercialization, scaling production technologies and expanding the Titanium Manufacturing Campus in Virginia, further development of the Camden-Titan project in Tennessee, and general corporate purposes. » More on de.investing.com

IperionX Limited stock fell about 14.4% after the company reported a $0.10 per share loss for the first half of fiscal 2026 and recorded no revenue. The company spent $34.8 million in the period, including $10.8 million on R&D and $31.1 million in capital expenditures, and holds $65.8 million in cash and equivalents. Analysts polled expect a smaller full-year loss and forecast profitability in fiscal 2027, but projected earnings are modest and an analyst called the stock a sell. » More on finance.yahoo.com